Frontlight ResearchEarly access
Active, not recruitingNo phase
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
Key facts
- Who runs it
- Cook Research Incorporated
- Where
- France, Germany, Italy, and Netherlands10 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 300 people, planned
- Started
- 6 Jul 2023
- Expected to end
- 1 Dec 2034
- Type of study
- Observational
- Treatments tested
- Endovascular aortic treatment
- Record updated
- 27 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Patient has been treated/was intended to be treated with ZTA according to the clinical practice from Jan 2019 until site initiation
- The patient is willing to participate in the study and provide written informed consent for study participation or express non-objection or give written consent per local requirements prior to data collection of any data from medical records
Who cannot take part
- A patient treated with a custom-made fenestrated and/or branched endovascular graft in conjunction with ZTA either during the same procedure or in a staged procedure
- A patient whose follow-up data collection is not possible (e.g. due to living abroad)
Where is this trial?
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to gather real-world clinical data demonstrating the continued safety and performance of the a marketed stent graft (Zenith® Alpha Thoracic Endovascular Graft [ZTA]) and collect longer term follow-up to better understand clinical outcomes associated with the expected lifetime of the device.
Treatments tested
- Endovascular aortic treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Post-market Clinical Follow up Study on Cook Medical Zenith® Alpha Thoracic Endovascular Grafts
- Record updated
- 27 February 2026